PHARMUNY
Board
1 director, 2 in day-to-day management, last change in February 2026- ,
Permanent representatives 1
Mandates through the years
10 names, the dashed line is todayDirector
Managing director
Managing director
Director
Director
Director
Director
Director
Statutory auditor
Director
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Director, since before 28-08-2014
- Managing director, until 23-12-2020
-
- Managing director, appointed by deed of 23-12-2020, still in office
-
- Managing director, appointed by deed of 23-12-2020, still in office
-
- Director, appointed by deed of 19-09-2016, until 24-02-2026
-
- Director, from before 28-08-2014 to 23-12-2020
- Director, from before 28-08-2014, no longer listed in the 2025 annual accounts
-
- Managing director, appointed by deed of 24-07-2018, until 23-12-2020
- Director, appointed by deed of 23-12-2020, ended, last mentioned on 23-12-2020
-
- Director, appointed by deed of 28-12-2016, until 15-07-2019
-
- Director, from before 28-08-2014 to 30-06-2018
-
- Statutory auditor, appointed by deed of 30-05-2017, until 30-05-2017
-
- Director, appointed by deed of 19-09-2014, no longer listed in the 2025 annual accounts
Control
Parent
Equity €449,369
Profit €89,112 in 2025 (profit €95,051 in 2024)
Checked score
Source: accounts 2025
99.84%
This company
PHARMUNY
Equity €309,069
Profit €121,007 in 2025
Capital
- Capital
- €61,500
- Shares
- 1,250 in the deed of 30-05-2017
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
-
- 2021 to 2024: 99.84%
Source: lists of holdings in the owners' accounts
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 30-05-2017 ↗
- 624 shares
- 624 shares
- 2 shares
Capital over time
- 23-08-2017 Capital reduction of €466,094.60
- 23-08-2017 Capital increase of €24,200.16 · to €49,123.73 · from reserves
- 23-08-2017 Capital increase of €12,376.27 · to €61,500 · from reserves
- 30-05-2017 Capital stated in the deed · €198,533.84 · 1,250 shares